StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) income statement

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$26.90−0.55 (-2.00%)

Close on Nov 18, 2026Market cap $1.30BP/E –Yield –

Nanobiotix S.A. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-33.2%
Net margin
-73.5%
Return on equity, FY2025
–

Financial strength

Current ratio
1.44
Debt to equity
–
Debt to assets
–
Cash to current liabilities
129.0%

Valuation

P/E ratio
–
Price to sales
36.21
Price to book
–
Dividend yield
–

See a number that looks wrong?